BiotechTube

Vancomycin Pre-Treatment + Placebo for Vancomycin Pre-Treatment + SER-287 + Placebo for SER-287

Phase 2Terminated
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ulcerative Colitis

Conditions

Ulcerative Colitis

Trial Timeline

Dec 19, 2018 → Oct 13, 2021

NCT ID
NCT03759041

About Vancomycin Pre-Treatment + Placebo for Vancomycin Pre-Treatment + SER-287 + Placebo for SER-287

Vancomycin Pre-Treatment + Placebo for Vancomycin Pre-Treatment + SER-287 + Placebo for SER-287 is a phase 2 stage product being developed by Seres Therapeutics for Ulcerative Colitis. The current trial status is terminated. This product is registered under clinical trial identifier NCT03759041. Target conditions include Ulcerative Colitis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03759041Phase 2Terminated

Competing Products

20 competing products in Ulcerative Colitis

See all competitors
ProductCompanyStageHype Score
Mirikizumab SC + Mirikizumab IV + Placebo SCEli LillyPhase 3
77
MirikizumabEli LillyPhase 2
52
Azathioprine + PlaceboCelltrionApproved
85
CT-P13 SC (Infliximab)CelltrionPhase 3
77
Afimkibart + PlaceboChugai PharmaceuticalPhase 3
77
TacrolimusAstellas PharmaPhase 3
77
tacrolimus + PlaceboAstellas PharmaPhase 3
77
Filgotinib MaleateEisaiApproved
85
AJM300 + PlaceboEisaiPhase 3
77
GSK3050002 + PlaceboEisaiPhase 1
33
adalimumab + placeboEisaiPhase 3
77
E6007 + PlaceboEisaiPhase 2
52
KHK4083 + PlaceboKyowa KirinPhase 2
52
KHK4083 + PlaceboKyowa KirinPhase 1
33
Arm1 + Arm 2Zydus LifesciencesPhase 2
52
Mirikizumab + MirikizumabEli LillyPhase 3
77
Mirikizumab IV + Mirikizumab SC + Vedolizumab IV + Placebo IV + Placebo SCEli LillyPhase 3
77
LY3471851 + PlaceboEli LillyPhase 2
52
Mirikizumab + PlaceboEli LillyPhase 2
52
LY4268989 + PlaceboEli LillyPhase 2
52

Other Products from Seres Therapeutics

SER-109 + PlaceboPhase 3
69
SER-109Phase 3
69
SER-109 + PlaceboPhase 2
44
Placebo for antibiotic + Vancomycin pretreatment + Nivolumab + Matching Placebo for SER-401 + SER-401Phase 1
25
SER-262 + PlaceboPhase 1
25